Outcomes of intravascular brachytherapy for recurrent drug‐eluting in‐stent restenosis

2020 ◽  
Author(s):  
Michael Megaly ◽  
Matthew Glogoza ◽  
Iosif Xenogiannis ◽  
Evangelia Vemmou ◽  
Ilias Nikolakopoulos ◽  
...  
Keyword(s):  
Stent Restenosis ◽  
Intravascular Brachytherapy ◽  
Drug Eluting ◽  
In Stent Restenosis

OUTCOMES OF INTRAVASCULAR BRACHYTHERAPY IN RECURRENT DRUG-ELUTING IN-STENT RESTENOSIS

2020 ◽  
Vol 75 (11) ◽  
pp. 1151
Author(s):  
Michael Megaly ◽  
Matthew Glogoza ◽  
Iosif Xenogiannis ◽  
Evangelia Vemmou ◽  
Ilias Nikolakopoulos ◽  
...  
Keyword(s):  
Stent Restenosis ◽  
Intravascular Brachytherapy ◽  
Drug Eluting ◽  
In Stent Restenosis

Outcomes with combined laser atherectomy and intravascular brachytherapy in recurrent drug-eluting in-stent restenosis

2020 ◽  
Author(s):  
Michael Megaly ◽  
Matthew Glogoza ◽  
Iosif Xenogiannis ◽  
Evangelia Vemmou ◽  
Ilias Nikolakopoulos ◽  
...  
Keyword(s):  
Stent Restenosis ◽  
Intravascular Brachytherapy ◽  
Drug Eluting ◽  
Laser Atherectomy ◽  
In Stent Restenosis

Coronary intravascular brachytherapy for recurrent coronary drug-eluting in-stent restenosis: A systematic review and meta-analysis

2020 ◽  
Author(s):  
Michael Megaly ◽  
Matthew Glogoza ◽  
Iosif Xenogiannis ◽  
Evangelia Vemmou ◽  
Ilias Nikolakopoulos ◽  
...  
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Stent Restenosis ◽  
Intravascular Brachytherapy ◽  
Drug Eluting ◽  
In Stent Restenosis

Drug-eluting Balloons in Coronary Artery Disease – Current and Future Perspectives

2012 ◽  
Vol 8 (1) ◽  
pp. 56 ◽  
Author(s):  
Anouar Belkacemi ◽  
Pierfrancesco Agostoni ◽  
Michiel Voskuil ◽  
Pieter Doevendans ◽  
Pieter Stella ◽  
...  
Keyword(s):  
Small Vessel Disease ◽  
Percutaneous Treatment ◽  
Added Value ◽  
High Concentration ◽  
Diffuse Disease ◽  
Stent Restenosis ◽  
Alternative Treatment Option ◽  
Drug Eluting ◽  
Drug Eluting Balloon ◽  
In Stent Restenosis

Percutaneous treatment of complex coronary lesions, such as small-vessel disease, diabetes and long diffuse disease, remain hampered by suboptimal results, even with the use of drug-eluting stents (DES). The paclitaxel drug-eluting balloon (DEB) is an interesting emerging device that optimises clinical outcomes in these specific lesions. The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers. Several studies have already shown promising and consistent results in the treatment of in-stent restenosis. The DEB has demonstrated its added value compared with certain DES. Inspired by these results, an increasing number of studies have been started in different coronary lesion subsets to explore the value of the DEB in a broader range of lesions. It will be interesting to see whether the DEB will find more indications beyond in-stent restenosis treatment. Moreover, will all DEBs offer the same added value, or will there be differences in efficacy among the DEBs produced by the various manufacturers? As was the case in the development of DES, now the puzzle pieces have to be put together for DEB.

scholarly journals TCTAP A-030 Drug Coated Balloon Versus Drug-eluting Stent for In-stent Restenosis After Drug-eluting Stent Implantation: A Meta-analysis

2021 ◽  
Vol 77 (14) ◽  
pp. S19
Author(s):  
Hendy Bhaskara Perdana Putra ◽  
Quri Meihaerani Savitri ◽  
Wally Wahyu Mukhammad ◽  
Atiyatum Billah ◽  
Alan Dharmasaputra ◽  
...  
Keyword(s):  
Stent Implantation ◽  
Meta Analysis ◽  
Drug Eluting Stent ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
Drug Coated Balloon ◽  
In Stent Restenosis

scholarly journals In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario

2019 ◽  
Vol 71 (1) ◽  
Author(s):  
Ganesh Paramasivam ◽  
Tom Devasia ◽  
Shabeer Ubaid ◽  
Ashwitha Shetty ◽  
Krishnananda Nayak ◽  
...  
Keyword(s):  
Real World ◽  
Clinical Presentation ◽  
Drug Eluting Stents ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
In Stent Restenosis

scholarly journals CRT-48 Drug Eluting Balloon for De-Novo, In stent Restenosis and Bifurcation Lesions of Coronary Artery Disease: Short and Intermediate Results, Prospective Registry

2013 ◽  
Vol 6 (2) ◽  
pp. S16-S17
Author(s):  
Saad Mohamed Al Kasab ◽  
Menwar Mutared Al Anazi ◽  
Ali AlMasood ◽  
Mohammed AlKasab ◽  
Rida Nourallah
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
De Novo ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
Bifurcation Lesions ◽  
Intermediate Results ◽  
Artery Disease ◽  
Drug Eluting Balloon ◽  
In Stent Restenosis

scholarly journals Efficacy of Drug-Eluting Balloon in the Treatment of Ostial Left Anterior Descending Artery In-Stent Restenosis

2014 ◽  
Vol 22 (2) ◽  
pp. 183-187
Author(s):  
Guy Fernando de Almeida Prado ◽  
Cristiano Guedes Bezerral ◽  
Gustavo Martins Pereira Alves ◽  
Marcio Augusto Meirelles Truffa ◽  
Expedito Eustaquio Ribeiro da Silva ◽  
...  
Keyword(s):  
Left Anterior Descending Artery ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
Drug Eluting Balloon ◽  
In Stent Restenosis
Sign in / Sign up

Export Citation Format

Share Document